Secondhand Smoke Exposure Worse For Toddlers, Obese Children

Thu, 19 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/171516.php

Toddlers and obese children suffer more than other youth when exposed to secondhand smoke, according to research presented at the American Heart Association's Scientific Sessions 2009. "Secondhand smoke in children is not just bad for respiratory issues, as has been previously described by other researchers," said John Anthony Bauer, Ph.D.

Endologix Receives IDE Approval For Fully Percutaneous Approach To EVAR

Thu, 19 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/171450.php

Endologix, Inc.

Vitamin B Niacin Offers No Additional Benefit To Statin Therapy In Seniors Already Diagnosed With Coronary Artery Disease

Thu, 19 Nov 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/171416.php

The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.

Highlights Of NHLBI-Supported Research Presented At American Heart Association's Scientific Sessions

Thu, 19 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/171391.php

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.

Egyptian Mummies Reveal Heart Disease As Ancient Affliction

Wed, 18 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/171316.php

A new study finds that atherosclerosis, hardening of the arteries, was common in ancient Egyptians, challenging a belief that vascular disease is a modern affliction caused by current-day risk factors such as stress and sedentary lifestyles. Michael Miyamoto, MD, a graduate of the UC San Diego School of Medicine and assistant clinical professor, recently returned to the US following an expedition to Egypt to evaluate the prevalence of cardiovascular disease in 3,500-year-old mummies.

Thalidomide: Solving The 50-Year-Old Puzzle

Wed, 18 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/171350.php

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer.

New Consortium Paves The Way For Improved Treatment Of Hypertension And Associated Vascular Complications

Wed, 18 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/171289.php

Top Institute Pharma (TI Pharma) has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke.

Atrium Announces The Release Of Interim Results From COBEST Clinical Study

Wed, 18 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/171274.php

Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.

Scans Of Egyptian Mummies Show Hardening Of Arteries Is Not A Modern Disease

Wed, 18 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/171304.php

An international team of scientists who took CT scans of mummified bodies of people who lived in Egypt up to 3,500 years ago found evidence to suggest that hardening of arteries, a risk factor for heart attacks and strokes, is not a modern disease and may have been quite common among ancient Egyptians of high socioeconomic status.

Hand-Held Computer May Help Improve Pulmonary Embolism Diagnosis

Tue, 17 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/171191.php

Pulmonary embolism is a life-threatening condition most often caused by a blood clot breaking off from a vein and entering the circulatory system. While evidence-based guidelines exist to help physicians safely and efficiently evaluate patients with suspected pulmonary embolism, testing often differs from what is suggested. Researchers sought to determine if a computer program for use on a mobile, handheld device could improve diagnostic decision-making.

Effects Of Vitamin D Deficiency Amplified By Shortage Of Estrogen

Tue, 17 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/171130.php

Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov.

Hypothermia Research May Benefit Brain Injured Athletes

Mon, 16 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/171017.php

NFL players and other athletes who suffer serious or multiple concussions may benefit from ground-breaking research being conducted by scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center. The scientists are developing a surgical technique that involves hypothermia in specific regions of the brain. Therapeutic hypothermia is a medical treatment that lowers a patient's temperature in order to help reduce the risk of injury to tissue.

Nicast Announces Plans To Launch The NovaMesh™ Intra-Abdominal Hernia Mesh In Europe In Q1 2010

Thu, 12 Nov 2009 12:00:00 PST
http://www.medicalnewstoday.com/articles/170775.php

Nicast, developer of medical devices made of electrospun nanofabric, announced it is readying to launch the NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010, pending European regulatory approval. NovaMesh is the first intra-abdominal hernia mesh to utilize the special properties of electrospun nanofabric.

How The Body Prevents Formation Of Blood Vessels Has Implications For Cancer Treatment

Thu, 12 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/170760.php

Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research.

When Seconds Count: Interventional Radiology Treatment For Pulmonary Embolism Saves Lives

Thu, 12 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/170673.php

Catheter-directed therapy or catheter-directed thrombolysis--an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs--saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.

Erythropoiesis-Stimulating Agents Associated With Higher Risk Of Venous Thromboembolism

Wed, 11 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/170539.php

Use of erythropoiesis-stimulating agents is associated with an increased risk of venous thromboembolism, according to study published online November 10 in the Journal of the National Cancer Institute. Erythropoiesis-stimulating agents (i.e.

Drugs To Treat Anemia In Cancer Patients Linked To Thromboembolism

Wed, 11 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/170525.php

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. The findings will be published online on Nov.

Boston University School Of Medicine's Vasculitis Center Receives $6m Grant From National Institutes Of Health

Wed, 11 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/170477.php

The Vasculitis Center at Boston University School of Medicine (BUSM) has received a five-year $6 million grant from the National Institutes of Health. The grant will be used to research new biomarkers for vasculitis disease activity and prognosis. The research will also develop and standardize outcome measures for the different types of vasculitis, and develop and standardize imaging techniques for the large vessel vasculitides.

Onset Medical Receives U.S. FDA Marketing Clearance For The SoloPath™ TransFemoral Endovascular Access Catheter

Tue, 10 Nov 2009 06:00:00 PST
http://www.medicalnewstoday.com/articles/170455.php

Onset Medical Corporation announced today the Company has received U.S. FDA 510(k) marketing clearance for the Company's SoloPath™ TransFemoral Endovascular Access Catheter. Onset's SoloPath Endovascular Access Catheters are designed to provide access to diseased arteries at a relatively small catheter size and then be expanded to provide a conduit for the delivery of larger diameter devices.

$150,000 Grant To American College Of Phlebology Foundation Announced By Vein Clinics Of America

Mon, 09 Nov 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/170257.php

Vein Clinics of America (VCA) has announced its commitment of $150,000 to the American College of Phlebology Foundation (ACPF) over the next five years. All VCA physicians specialize in phlebology, the study of venous diseases and disorders. VCA, as one of the largest network of offices in the country dedicated to the minimally invasive treatment of vein disorders, announced the grant during the American College of Phlebology's Annual Congress in Palm Desert, Calif.

New Thrombosis Research Presented At CHEST 2009

Thu, 05 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/169943.php

Extended Therapy for Blood Clot Prevention Yields Greater Benefits in Hip/Knee Surgery (#8587) Patients undergoing total knee replacement (TKR) or total hip replacement (THR) surgeries may experience better outcomes if they receive extended therapy for the prevention of thrombosis (blood clots).

First Device Designed To Preserve Blood Flow To Iliac Arteries During Aneurysm Repair Receives Approval From Health Canada

Wed, 04 Nov 2009 21:00:00 PST
http://www.medicalnewstoday.com/articles/169852.php

Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the body's largest arteries with an endovascular graft delivered during a minimally invasive procedure without blocking a critical artery.

Statins May Prevent Blood Clots In Patients With Cardiovascular Disease

Wed, 04 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/169769.php

Statins may provide potentially life-saving benefits for patients with cardiovascular disease by helping reduce the incidence of blood clots.

Can Charcoal Fight Heart Disease In Kidney Patients?

Mon, 02 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/169474.php

Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Patients with advanced kidney disease have high rates of atherosclerosis ("hardening of the arteries") and death from heart disease.

Sight Gone, But Not Necessarily Lost?

Sat, 31 Oct 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/169389.php

Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight. Reporting in the Oct.